- Global Pharma News & Resources

PharmaLex expands France BENELUX region

PharmaLex expands France BENELUX region
The addition of Archemin BV strengthens PharmaLex’s existing expertise supporting the life science industry 

Frankfurt, Germany – March 11, 2021: PharmaLex Group, a leading provider of specialized services for the pharma, biotech and medtech industries worldwide, has completed the merger of Archemin BV to the PharmaLex Group

Established in 1999, Archemin is a well-established pharmaceutical consultancy based in Mechelen, Belgium. Headed by its founder Ludwig Everaert, and supported by Anne Peeters, Operations Manager, their multidisciplinary team of 16+ experts provide services to both domestic and international clients.

The merger complements our existing services by adding pharmacovigilance, quality management, medical information and market access consulting, allowing us to both increase our pool of expertise as well as our presence in the region. To build on our regional setting, Archemin will be a pivotal member of our France BENELUX region.

“We are really excited to be part of the PharmaLex Group”, explained Ludwig Evereart, Founder Archemin BV. “It not only allows us to continue to provide our excellent service to clients but also to be able to offer them a wider range of services with expertise across the globe”, he added. “We have worked with the team at Archemin on a number of key projects in the past”, explained Sophie Guillaume, Regional Managing Director, France and BENELUX. “Their expertise, particularly in market access, local regulatory as well as ad promo requirements and pharmacovigilance, is exemplary”, she added.

“Archemin have a strong presence in the BENELUX region and this is an important location for PharmaLex.”, explained Dr. Thomas Dobmeyer, CEO PharmaLex. “Strengthening our existing expertise in this region means we now have offices in all key areas in Europe”, he concluded.

Editor Details

Last Updated: 12-Mar-2021